Genmab A/S Stock

Genmab A/S Acquisitions (Net)

The Acquisitions (Net) of Genmab A/S (GMAB.CO) as of Aug 4, 2026 is -5.59 B USD. In the previous year, Acquisitions (Net) was -1.39 B USD — a change of 301.21% (lower).

Acquisitions (Net)

-5.59 BUSD

YoY

301.21%

Last updated:

Acquisitions (Net) of Genmab A/S is 2026 -5.59 B USD. Acquisitions (Net) of Genmab A/S was 2025 -1.39 B USD. It decreases by 301.21% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Acquisitions (Net) of Genmab A/S is -5.59 B USD in 2026.

Acquisitions (Net) of Genmab A/S changed from -1.39 B USD to -5.59 B USD, representing a 301.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Genmab A/S historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Genmab A/S

All Key Metrics — Genmab A/S